{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-237834","form_type":"8-K","ticker":"CORT","cik":"0001088856","company_name":"CORCEPT THERAPEUTICS INC","filed_at":"2025-10-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.765268+00:00","generated_at":"2026-05-17T03:50:48.840923+00:00","sec_items":["1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Corcept terminates distribution agreement with Optime Care, effective Jan 8, 2026","bullets":["Notice of termination of Distribution Services Agreement with Optime Care given Oct 10, 2025; effective Jan 8, 2026.","Optime had been specialty pharmacy distributor for Korlym and authorized generic mifepristone.","Exclusive provider status ended Sept 15, 2025; termination is for convenience under 90-day notice provision.","Original agreement dated Aug 4, 2017, amended and restated Apr 1, 2024, with term through Mar 31, 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-237834","json":"https://secwatch.observer/filing/0001193125-25-237834.json","markdown":"https://secwatch.observer/filing/0001193125-25-237834.md","text":"https://secwatch.observer/filing/0001193125-25-237834.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525237834/0001193125-25-237834-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525237834/d61706d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:50:48.840923+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}